Pfizer and BioNTech could secure emergency US and European authorisation for their Covid-19 vaccine next month after final trial results showed it had a 95pc success rate and no serious side effects, the drugmakers said yesterday.
Read more here:: Drug giants aim to speed up roll-out of successful vaccines
